What type of study is this?

September 10, 2025PharmaceuticalsOpen Access

Effects of CCL20/CCR6 Modulators in a T Cell Adoptive Transfer Model of Colitis

View Full Paper

Ask AI

Bookmark

Modulation of the ccl20/ccr6 axis in an adoptive transfer model shows negligible effects on colitis.
Daily treatment with MR120 or MR452 over 8 weeks reduced colonic myeloperoxidase activity, indicating some anti-inflammatory property.
The study employed an adoptive transfer model using immunocompromised mice to investigate the effects of two CCR6 antagonists.
Despite some beneficial effects, targeting the ccl20/ccr6 axis has limited impact on inflammatory bowel disease symptomatology.

No takes yet. Share an insight, caveat, or question.

Experimental analysis tests the efficacy of CCR6 antagonists in colitis, suggesting limited improvement in inflammatory bowel disease.

Allodi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark